Beyond the classical hallmarks of amyloid-β deposition and tau pathology, sustained neuroinflammation has gained increasing recognition as a core pathological feature of AD (Heppner et al., 2015; Harach et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.